CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
MF59-Adjuvanted seasonal influenza vaccine including H1N1 leads to robust serological response rates in immunocompromised patients after liver and kidney transplantation
DOI 10.1055/s-0032-1324010
Bibliografische Angaben
Nachweis in CareLit
Autor:innenK Wursthorn, S Pischke, J Buchta, B Zacher, A Müller-Heine, A Großhennig, C Schröder, C Blume, T Ganten, CP Strassburg, A Koch, MP Manns
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe08/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background and aims: Influenza infection in solid-organ transplant recipients leads to increased morbidity and mortality. Vaccination is preventive despite lower efficacy with approved non-adjuvanted vaccines. The aim of this study was to evaluate the immunogenicity and safety of the MF59-adjuvanted influenza vaccine 2010/11 (Fluad®) in liver/kidney transplant recipients under immunosuppression compared to healthy s…
Zitieren
Zitierempfehlung
K Wursthorn, S Pischke, J Buchta, B Zacher, A Müller-Heine, A Großhennig, C Schröder, C Blume, T Ganten, CP Strassburg, A Koch, MP Manns (2012) MF59-Adjuvanted seasonal influenza vaccine including H1N1 leads to robust serological response rates in immunocompromised patients after liver and kidney transplantation. Zeitschrift für Gastroenterologie (08). https://doi.org/10.1055/s-0032-1324010
Mit CareLit weiterarbeiten